IP Library Granted Patent US 10,627,411
Granted Patent B2
US 10,627,411 · App. 15/128,923 · Granted Apr 21, 2020

T-cell epitope identification

Inventors: Robert Holt (Vancouver, CA); Govinda Sharma (Vancouver, CA)
Assignee: British Columbia Cancer Agency Branch
G01N33/6878C12N15/1037C12N15/1086C12Q1/6886G01N33/5091G01N33/56972G01N33/6845C12Q2600/158
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,627,411
App. No.
15/128,923
Granted
Apr 21, 2020
Kind
B2
Abstract

The present invention is a method for determining the identity of the epitopes recognized by T-cells. The method consists of expressing an encoded library of candidate epitope sequences in a recipient reporter cell capable of providing a detectable signal upon cytotoxic attack from a single cognate T-cell followed by contacting the reporter cells with T-cells of interest. The reporter cells with a single indicating cytotoxic attack from a T-cell are isolated and then analyzed by next-generation sequencing in order to identify the epitope sequences. Specifically disclosed is a method in which a library of candidate epitope-encoding nucleic acids are expressed in cells which feature a membrane-bound major histocompatibility complex (MHC) protein, said library produced by transfection of plasmids featuring both a nucleotide encoding the candidate epitope and a nucleotide encoding a FRET-based fluorescent protein cleaved by granzyme.

Claims (19)

1. A method for determining epitopes recognized by cytotoxic T-cells, the method comprising the steps of:

expressing a library of candidate epitope-encoding nucleic acids in reporter cells capable of presenting expressed peptides of such candidate epitope-encoding nucleic acids in the context of a membrane-bound major histocompatibility complex (MHC) protein wherein the reporter cells are modified to carry a fluorescence-based signaling system in their cytosols that generates a fluorescent signal whenever a peptide linkage in the system is enzymatically cleaved by a granzyme A, B, H, K or M from granules of a cytotoxic T cell upon recognition of an expressed peptide in the context of an MHC protein on a reporter cell by such cytotoxic T cell;

contacting in a reaction mixture a mixed population of the reporter cells expressing different candidate epitope-encoding nucleic acids of the library with a sample comprising cytotoxic T-cells, wherein effector functions of cytotoxic I-cells recognizing reporter cells are activated so that granzyme A, H, K or M in granules of the Cytotoxic T-cells are delivered by, a granzyme-perforin pathway to recognized reporter cells and cause a fluorescent signal to be venerated by the reporter cells;

isolating intact reporter cells generating fluorescent signals;

extracting candidate epitope-encoding nucleic acids from the isolated intact reporter cells; and

sequencing the candidate epitope-encoding nucleic acids of the reporter cells to identify the epitope-encoding nucleic acids.

2. The method of claim 1 wherein said sample is from an individual and said MHC proteins of said reporter cells are matched with MHC proteins expressed by the individual.

3. The method of claim 2 wherein said reporter cells comprise autologous cells of said individual genetically modified to express candidate epitopes of said library.

4. The method of claim 3 wherein said autologous cells are B cells of said individual.

5. The method of claim 4 wherein said autologous cells are stably transfected or transformed by a vector capable of expressing said candidate epitopes of said library.

6. The method of claim 3 wherein said reporter cells are genetically modified to express a FRET-based fluorescent protein signaling system that generates a fluorescent signal whenever enzymatically cleaved by one of said granzyme A, B, H, K or M.

7. A method for determining epitopes recognized by cytotoxic T-cells, the method comprising the steps of:

(a) expressing a library of candidate epitope-encoding nucleic acids or an enriched library of candidate epitope-encoding nucleic acids in reporter cells capable of presenting expressed peptides of such candidate epitope-encoding nucleic acids in the context of a membrane-bound major histocompatibility complex (MHC) protein wherein the reporter cells are modified to carry a fluorescence-based signaling system that generates a fluorescent signal whenever a peptide linkage in the system is enzymatically cleaved by a granzyme A, B, H, K or M from granules of a granzyme-perforin pathway of a cytotoxic T cell upon recognition of an expressed peptide in the context of an MHC protein on a reporter cell by such cytotoxic T cell;

(b) contacting in a reaction mixture a mixed population of the reporter cells expressing different candidate epitope-encoding nucleic acids of the library with a sample comprising cytotoxic T-cells;

(c) isolating reporter cells generating a fluorescent signal indicating recognition by a cytotoxic T-cell;

(d) extracting candidate epitope-encoding nucleic acids from the isolated reporter cells and generating therefrom an enriched library of candidate epitope-encoding nucleic acids;

(e) repeating steps (a)-(d) with the enriched library of candidate epitope-encoding nucleic acids until a frequency of reporter cells generating the signal indicating recognition by a cytotoxic T-cell is greater than or equal to a predetermined value;

(f) sequencing the candidate epitope-encoding nucleic acids of reporter cells generating said signal to identify sequences of the epitope-encoding nucleic acids.

8. The method of claim 7 wherein said step of isolating includes sorting said reporter cells by a fluorescently activated cell sorter (FACS).

Assignments (1)
MERGER Recorded Aug 19, 2020
From: BRITISH COLUMBIA CANCER AGENCY BRANCH
To: PROVINCIAL HEALTH SERVICES AUTHORITY
Reel/Frame 053555/0968 →
Continuity (2)
Provisional Application 61971355 · Mar 27, 2014
Related Publication 20180052176A1 · Feb 22, 2018